| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |